FeaturesSignalPricingFounders
AV

Avalon Ventures

Venture CapitalActive

Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.

La Jolla, United StatesFounded 2008avalon-ventures.com/
166
Investments
10
Exits
AUM
6.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Avalon Ventures.

Get started free

Investment Thesis & Strategy

Avalon Ventures invests in early-stage information technology and life sciences companies. They typically invest in companies that are developing innovative technologies in these sectors.

Investment Activity

Deals per year over the last 12 years

2
2003
0
2004
2
2005
1
2006
1
2007
0
2008
1
2009
0
2010
0
2011
0
2012
0
2013
1
2014

Portfolio Companies

Selected investments from their portfolio of 166 companies

X
Xencor
Biotech · Series A, 0
Active
O
Onyx Pharmaceuticals
Biotech · Series A, 0
Active
N
NextWave Wireless
Other · Series A, 0
Active
S
Sequenom
Biotech · Series A, 0
Active
C
Corvus Pharmaceuticals
Biotech · Series A, 2014
Active
R
Roka Bioscience
Biotech · Series A, 2009
Active
F
Fate Therapeutics
Biotech · Series A, 2007
Active
S
Symphogen
Biotech · Series A, 2006
Active
R
Receptos
Biotech · Series A, 2005
Active
C
Conatus Pharmaceuticals
Biotech · Series A, 2005
Active
A
Ambit Biosciences
Biotech · Series A, 2003
Active
A
Achaogen
Biotech · Series A, 2003
Active

Notable Exits

CompanyTypeYearValue / Acquirer
ViaCyteAcquisition2022
SymphogenAcquisition2020$276M
Kura OncologyIPO2014
AchaogenIPO2014
Ambit BiosciencesAcquisition2014$410M
Onyx PharmaceuticalsAcquisition2013$10.4B
Fate TherapeuticsIPO2013
Ardea BiosciencesAcquisition2012$320M
SequenomIPO2000
IlluminaIPO2000

Frequently Asked Questions

Avalon Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors